26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cationic Antimicrobial <strong>Peptide</strong>s 159<br />

70. Weaver, D.C. (2004). Applying data mining techniques to library design, lead generation<br />

and lead optimization. Curr. Opin. Chem. Biol. 8, 264–270.<br />

71. Lejon, T., Strom, M.B., and Svendsen, J.S. (2001) Antibiotic activity of pentadecapeptides<br />

modelled from amino acid descriptors. J. Pept. Sci. 7, 74–81.<br />

72. Lejon, T., Stiberg, T., Strom, M.B., and Svendsen, J.S. (2004) Prediction of<br />

antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.<br />

J. Pept. Sci. 10, 329–335.<br />

73. Strom, M.B., Stensen, W., Svendsen, J.S., and Rekdal, O. (2001) Increased antibacterial<br />

activity of 15-residue murine lactoferricin derivatives. J. Pept. Res. 57,<br />

127–139.<br />

74. Jenssen, H., Gutteberg, T.J., and Lejon, T. (2005) Modeling of anti-HSV activity of<br />

lactoferricin analogues using amino acid descriptors. J. Pept. Sci. 11, 97–103.<br />

75. Hellberg, S., Sjostrom, M., Skagerberg, B., and Wold, S. (1987) <strong>Peptide</strong> quantitative<br />

structure-activity relationships, a multivariate approach. J. Med.Chem. 30,<br />

1126–1135.<br />

76. Frecer, V., Ho, B., and Ding, J.L. (2004) De novo design of potent antimicrobial<br />

peptides. Antimicrob. Agents Chemother. 48, 3349–3357.<br />

77. Frece, V. (2006) QSAR analysis of antimicrobial and haemolytic effects of cyclic<br />

cationic antimicrobial peptides derived from protegrin-1. Bioorgan. Medic. Chem.<br />

14, 6065–6074.<br />

78. Ostberg, N., and Kaznessis, Y. (2004) Protegrin structure–activity relationships:<br />

using homology models of synthetic sequences to determine structural characteristics<br />

important for activity. <strong>Peptide</strong>s 26, 197–206.<br />

79. Cherkasov, A. (2005) Inductive QSAR descriptors. Distinguishing compounds with<br />

antibacterial activity by artificial neural networks. Int. J. Mol. Sci. 6, 63–86.<br />

80. Cherkasov, A. (2005) ‘Inductive’ descriptors. 10 successful years in QSAR. Curr.<br />

Computer-Aided <strong>Drug</strong> <strong>Design</strong> 1, 21–42.<br />

81. Cherkasov, A. (2003) Inductive electronegativity scale. Iterative calculation of<br />

inductive partial charges. J. Chem. Inf. Comp. Sci. 43, 2039–2047.<br />

82. Cherkasov, A., Shi, Z., Fallahi, M., and Hammond, G.L. (2005) Successful in silico<br />

discovery of novel non-steroidal ligands for human sex hormone binding globulin.<br />

J. Med. Chem. 48, 3203–3213.<br />

83. Karakoc, E., Sahinalp, S.C., and Cherkasov, A. (2006) Comparative QSAR- and<br />

fragments distribution analysis of drugs, druglikes, metabolic substances, and<br />

antimicrobial compounds. J. Chem. Inf. Model. 46, 2167–2182.<br />

84. Karakoc, E., Cherkasov, A., and Sahinalp, S.C. (2006) Distance based algorithms<br />

for small biomolecule classification and structural similarity search. Bioinformatics<br />

15, 243–251.<br />

85. Molecular Operational Environment. (2004) Chemical Computation Group Inc.,<br />

Montreal, Canada.<br />

86. SNNS: Stuttgart Neural Network Simulator, version 4.2, from University<br />

of Tübingen, Stuttgart, Germany. Available at http://www-ra.informatik.unituebingen.de/SNNS/.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!